Skip to content

Zymeworks ZYME Accounts Receivable

Accounts Receivable at other companies

Pfizer logo
PfizerPFE
$12.59B+6.2%
Amgen logo
AmgenAMGN
$9.14B+12.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$25.75M+44.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$39.16M-38.4%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$4.45M+236%
Septerna, Inc. logo
Septerna, Inc.SEPN
$10.84M+4,237%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's accounts receivable?
Zymeworks (ZYME) reported accounts receivable of $4.67M in Q1 2026.
How has Zymeworks's accounts receivable changed year-over-year?
Zymeworks's accounts receivable decreased by 81.0% year-over-year, from $24.59M to $4.67M.
What is the long-term trend for Zymeworks's accounts receivable?
Over 3 years (2022 to 2025), Zymeworks's accounts receivable has grown at a 28.8% compound annual growth rate (CAGR), from $28.65M to $61.22M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.